Study to Evaluate Efficacy and Safety of Benralizumab in Reducing Oral Corticosteroid Use in Adult Patients With Severe Asthma
Clinical trial NCT03557307 · COMPLETED
Trial details
- NCT number
- NCT03557307
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-01
- Primary completion
- 2021-04-16
- Enrollment
- 598
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.